Mettler-Toledo (MTD) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $28.34B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Diagnostics & Research |
| Country | US | CEO | Patrick K. Kaltenbach |
| IPO Date | 1997-11-14 | CAGR | 5.59% |
| Employees | 16,600 | Website | www.mt.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 2.6% | Total Yield | 2.6% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $27.48B | P/E | 32.23 | Forward P/E | 27.13 | PEG | 1.73 |
| P/S | 7.25 | P/B | 2319.11 | P/CF | 30.5 | P/FCF | 34.59 |
| Sales | $4.13B | Sales 1Y | 6.91% | Sales 3Y | 4.54% | Sales 5Y | 18.99% |
| EPS | $43.51 | EPS 1Y | 12.6% | EPS 3Y | 11.84% | EPS 5Y | 48.9% |
| Sales QoQ | 8.47% | EPS QoQ | 38.32% | Sales QoQ Avg | 1.69% | EPS QoQ Avg | 9.68% |
| Gross Margin | 59.3% | Operating Margin | 28.69% | Profit Margin | 21.91% | ROCE | 48.01% |
| ROA | 25% | ROE | -1200% | Altman Z Score | 10.58 | Piotroski Score | 7 |
| Current Ratio | 1.12 | Quick Ratio | 0.78 | Cash Ratio | 0.04 | Op. CF Ratio | 0.26 |
| Debt/Equity | 164.7 | Debt/Assets | 0.58 | Lt Debt/Equity | 159.45 | Lt Debt/Cap. | 0.99 |
| Intrst Cov. | 17.11 | Inventory Turnover | 4.09 | Asset Turnover | 1.13 | Receivables Turnover | 5.65 |
| Enterprise Value | $27.48B | P/E Ratio | 32.23 |
| Forward P/E | 27.13 | PEG Ratio | 1.73 |
| P/S Ratio | 7.25 | P/B Ratio | 2319.11 |
| P/CF Ratio | 30.5 | P/FCF Ratio | 34.59 |
| EPS | $43.51 | EPS Growth 1Y | 12.6% |
| EPS Growth 3Y | 11.84% | EPS Growth 5Y | 48.9% |
| Revenue Growth 1Y | 6.91% | Gross Margin | 0.59% |
| Operating Margin | 0.29% | Profit Margin | 0.22% |
| ROE | -12% | ROA | 0.25% |
| ROCE | 0.48% | Current Ratio | 1.12 |
| Quick Ratio | 0.78 | Cash Ratio | 0.04 |
| Debt/Equity | 164.7 | Interest Coverage | 17.11 |
| Altman Z Score | 10.58 | Piotroski Score | 7 |
Mettler-Toledo (MTD) valuation & financials
Mettler-Toledo (MTD) has a market capitalization of $28.34B and trades at a price-to-earnings ratio of 32.2. It operates in the Healthcare sector (Medical - Diagnostics & Research).
Mettler-Toledo's revenue grew +6.9% over the last year.
Mettler-Toledo's next earnings report is scheduled for November 5, 2026 after market close; analysts estimate EPS of $12.11. Check the earnings calendar to see all companies reporting this week.
Mettler-Toledo (MTD) — frequently asked questions
When does Mettler-Toledo (MTD) report earnings next?
Mettler-Toledo is expected to report earnings on November 5, 2026 after market close. Analysts estimate EPS of $12.11.
What is Mettler-Toledo's market cap?
Mettler-Toledo (MTD) has a market capitalization of $28.34B.
What is MTD's P/E ratio?
Mettler-Toledo trades at a price-to-earnings ratio of 32.2, with trailing twelve-month EPS of $43.51.
How fast is Mettler-Toledo growing?
Mettler-Toledo's revenue grew +6.9% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)